4.6 Article

Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds

期刊

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp.2009.202150

关键词

-

资金

  1. INSERM
  2. European Union [LSHM-CT-2004-503304, FP7-People PIAP-2008-230596, FP7-Health 2007-B 223143, 01GM0807, 01GM0820, 01GM0864, ANR-07-E-RARE-005-01/R07202DS]
  3. Programme Hospitalier de Recherche Clinique
  4. German Research Council (BMBF) [01GM0807, 01GM0603, 09GM0820, 01GM0644]
  5. HSP-Selbsthilfegruppe Deutschland eV
  6. Deutsche Forschungsgemeinschaft [SCHO754/3-1, SCHO754/4-1]
  7. Volkswagen Foundation [I/80711]
  8. Agence Nationale pour la Recherche [ANR-07-NEURO-041-01/R07047DS]
  9. Stiftung fur Pathobiochemie und Molekulare Diagnostik

向作者/读者索取更多资源

Background At least 28 loci have been linked to autosomal dominant spinocerebellar ataxia (ADCA). Causative genes have been cloned for 10 nucleotide repeat expansions (SCA1, 2, 3, 6, 7, 8, 10, 12, 17 and 31) and six genes with classical mutations (SCA5, 13, 14, 15/16, 27 and 28). Recently, a large British pedigree linked to SCA11 has been reported to carry a mutation in the TTBK2 gene. In order to assess the prevalence and phenotypic spectrum of SCA11, the authors screened 148 index patients of predominantly German (n=69) and French (n=79) descent with ADCA tested negative for a panel of SCA mutations (SCA1, 2, 3, 6, 7 and 17), for mutations in TTBK2. Methods In the German ADCA cohort, the complete coding sequence of the TTBK2 gene was PCR-amplified and screened for mutations by high-resolution-melting (HRM) analysis. In the French cohort, exons known to carry mutations were directly sequenced. For both cohorts, the gene-dosage alterations were assessed using a customised multiplex ligation probe amplification (MLPA) assay. Results In two of 148 ADCA families-one German and one French-the authors identified a potentially disease-causing SCA11 mutation. Interestingly, both carried an identical two-basepair deletion (c.1306_1307delGA, p.D435fs448X in exon 12) leading to a premature stop codon. Gene-dosage alterations were not detected in the TTBK2 gene. Clinically, the SCA11 patients had phenotypic characteristics as described before presenting with slowly progressive almost pure cerebellar ataxia with normal life expectancy. Conclusion SCA11 presented as ADCA III according to Harding's classification and is a rare cause of spinocerebellar ataxia in Caucasians accounting for less than 1% of dominant ataxias in central Europe.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Biochemistry & Molecular Biology

Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations

Annemieke Aartsma-Rus, Willeke van Roon-Mom, Marlen Lauffer, Christine Siezen, Britt Duijndam, Tineke Coenen-de Roo, Rebecca Schuele, Matthis Synofzik, Holm Graessner

Summary: Splice-modulating antisense oligonucleotides (ASOs) provide treatment options for rare neurological diseases with rare mutations, and patient-specific ASOs need to be developed. The 1 Mutation 1 Medicine (1M1M) and Dutch Center for RNA Therapeutics (DCRT) aim to develop and treat eligible patients with patient-specific ASOs in Europe and the Netherlands, respectively, under a named patient setting.
Article Neurosciences

Speech and Nonspeech Parameters in the Clinical Assessment of Dysarthria: A Dimensional Analysis

Wolfram Ziegler, Theresa Schoelderle, Bettina Brendel, Verena Risch, Stefanie Felber, Katharina Ott, Georg Goldenberg, Mathias Vogel, Kai Boetzel, Lena Zettl, Stefan Lorenzl, Renee Lampe, Katrin Strecker, Matthis Synofzik, Tobias Lindig, Hermann Ackermann, Anja Staiger

Summary: This study investigated the relationship between commonly used nonspeech parameters in clinical dysarthria assessment and the speech characteristics of dysarthria in individuals with movement disorders. The findings suggest that the nonspeech parameters currently used in dysarthria diagnostics do not align with diagnostic measures of speech characteristics in individuals with dysarthria.

BRAIN SCIENCES (2023)

Article Biochemistry & Molecular Biology

Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease

Tama Dinur, Peter Bauer, Christian Beetz, Claudia Cozma, Michal Becker-Cohen, Majdolen Istaiti, Arndt Rolfs, Volha Skrahina, Ari Zimran, Shoshana Revel-Vilk

Summary: Glucosylsphingosine (lyso-Gb1), the deacylated form of glucocerebroside, is a specific and sensitive biomarker for diagnosing Gaucher disease (GD). This study assessed the impact of lyso-Gb1 levels at the time of diagnosis on treatment decisions in newly diagnosed GD patients. The findings suggest that higher lyso-Gb1 levels are associated with the initiation of GD-specific therapy, especially among mildly affected patients. However, the exact cutoff value may vary due to differences in measurement methodologies and units between laboratories.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Medical Laboratory Technology

Autosomal Recessive Renal Hypouricemia Type 2 Presenting with Childhood Stroke in a Sri Lankan Child

P. Mihika S. Fernando, R. A. Saraji R. Gunasekara, Sabine Schroeder, Christian Beetz, Anura Jayawardena, Eresha A. Jasinge

LABORATORY MEDICINE (2023)

Article Health Care Sciences & Services

SARAspeech-Feasibility of automated assessment of ataxic speech disturbance

M. Grobe-Einsler, J. Faber, A. Taheri, J. Kybelka, J. Raue, J. Volkening, F. Helmhold, M. Synofzik, T. Klockgether

Summary: Ataxias refer to a group of movement disorders, characterized by progressive loss of balance, impaired coordination, and speech disturbance, resulting in a significant reduction in quality of life. Although speech disturbance can be clinically diagnosed, there is a lack of objective methods for assessing its severity. Through the analysis of 71 sets of speech recordings from ataxia patients, an automated classification system was developed. This system correctly predicted the expert ratings of speech disturbance in 80% of cases, demonstrating the feasibility of computer-assisted voice analysis for automated assessment of speech disturbance severity.

NPJ DIGITAL MEDICINE (2023)

Letter Clinical Neurology

As Frequent as Polyglutamine Spinocerebellar Ataxias: SCA27B in a Large German Autosomal Dominant Ataxia Cohort

Holger Hengel, David Pellerin, Carlo Wilke, Zofia Fleszar, Bernard Brais, Tobias Haack, Andreas Traschuetz, Ludger Schoels, Matthis Synofzik

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Frequency and Phenotype of RFC1 Repeat Expansions in Bilateral Vestibulopathy

Andreas Traschuetz, Felix Heindl, Muhammad Bilal, Annette M. Hartmann, Claudia Dufke, Olaf Riess, Andreas Zwergal, Dan Rujescu, Tobias Haack, Matthis Synofzik, Michael Strupp

Summary: Bilateral vestibulopathy is a chronic neurological disorder with unknown monogenic cause. This study identifies replication factor complex subunit 1 repeat expansions as a common cause of the disease and provides detailed characterization of its features and progression.

NEUROLOGY (2023)

Article Biology

Altered brain dynamics index levels of arousal in complete locked-in syndrome

Federico Zilio, Javier Gomez-Pilar, Ujwal Chaudhary, Stuart Fogel, Tatiana Fomina, Matthis Synofzik, Ludger Schols, Shumei Cao, Jun Zhang, Zirui Huang, Niels Birbaumer, Georg Northoff

Summary: EEG-based measures such as power-law exponent (PLE) and Lempel-Ziv complexity (LZC) can be used to identify biomarkers associated with complete locked-in syndrome (CLIS), allowing for better treatment and communication options.

COMMUNICATIONS BIOLOGY (2023)

Article Clinical Neurology

Comparison of Live and Remote Video Ratings of the Scale for Assessment and Rating of Ataxia

Arian Taheri Amin, Jennifer Faber, Demet Onder, Okka Kimmich, Matthis Synofzik, Tetsuo Ashizawa, Thomas Klockgether, Marcus Grobe-Einsler

Summary: After conducting comprehensive SARA assessments on video recordings of 69 patients with cerebellar ataxia, it was found that there was a high level of agreement between live ratings by site investigators and remote video ratings by experienced ataxia clinicians, indicating that remote video ratings are a reliable means to assess the severity of ataxia.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients

Catherine Ashton, Elisabetta Indelicato, David Pellerin, Guillemette Clement, Matt C. Danzi, Marie-Josee Dicaire, Celine Bonnet, Henry Houlden, Stephan Zuechner, Matthis Synofzik, Phillipa J. Lamont, Mathilde Renaud, Sylvia Boesch, Bernard Brais

Summary: Ashton C et al report a retrospective multi-centre cohort study of 34 patients from Canada, France, Austria and Australia with spinocerebellar ataxia 27B. The study describes the common feature of episodic ataxia and other episodic features, and also highlights the ineffectiveness of acetazolamide in these patients.

BRAIN COMMUNICATIONS (2023)

Article Neurosciences

Standards of Fluid Biomarker Collection and Pre-analytical Processes in Humans and Mice: Recommendations by the Ataxia Global Initiative Working Group on Biomarkers

Filippo Santorelli, Hayley McLoughlin, Justin Wolter, Daniele Galatolo, Matthis Synofzik, David Mengel, Puneet Opal

Summary: The Ataxia Global Initiative (AGI) aims to facilitate clinical trial readiness for hereditary ataxias by addressing the lack of objective measures for disease study and treatment evaluation. The AGI fluid biomarker working group has developed protocols to standardize sampling and storage of biomarkers for both human and mouse studies, with the goal of reducing variability and improving statistical power in downstream analysis. Emphasis has been placed on harmonizing minimal biological sample collection and storage, while optional protocols are available for advanced biofluid processing and storage.

CEREBELLUM (2023)

Correction Clinical Neurology

The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors (vol 270, pg 944, 2023)

Holger Hengel, Peter Martus, Jennifer Faber, Paola Giunti, Hector Garcia-Moreno, Nita Solanky, Thomas Klockgether, Kathrin Reetz, Bart P. van de Warrenburg, Magda M. Santana, Patrick Silva, Ines Cunha, Luis Pereira de Almeida, Dagmar Timmann, Jon Infante, Jeroen de Vries, Manuela Lima, Paula Pires, Khalaf Bushara, Heike Jacobi, Chiadi Onyike, Jeremy D. Schmahmann, Jeannette Huebener-Schmid, Matthis Synofzik, Ludger Schoels

JOURNAL OF NEUROLOGY (2023)

Article Genetics & Heredity

Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage

Sandra Martins, Ashraf Yahia, Ines P. D. Costa, Hassab E. Siddig, Rayan Abubaker, Mahmoud Koko, Marc Corral-Juan, Antoni Matilla-Duenas, Alexis Brice, Alexandra Durr, Eric Leguern, Laura P. W. Ranum, Antonio Amorim, Liena E. O. Elsayed, Giovanni Stevanin, Jorge Sequeiros

Summary: Machado-Joseph disease (MJD/SCA3) is the most common dominant ataxia worldwide, caused by a (CAG)n expansion. This study reports the first diagnosed MJD case in Sudan, with genetic analysis revealing shared ancestry with Portuguese, Spanish, and North American families. The STR-based haplotype of the Sudanese patients is distinct, indicating a unique genetic background.

HUMAN GENETICS (2023)

Article Neurosciences

Health-Related Quality of Life in Patients with Spinocerebellar Ataxia: a Validation Study of the EQ-5D-3L

Maresa Buchholz, Niklas Weber, Anika Raedke, Jennifer Faber, Tanja Schmitz-Huebsch, Heike Jacobi, Feng Xie, Thomas Klockgether, Bernhard Michalowsky

Summary: The study confirmed an acceptable, reliable, valid, and responsive EQ-5D-3L in SCA patients, measuring HRQoL adequately, besides well-established clinical instruments.

CEREBELLUM (2023)

暂无数据